Jennifer Jarrett
CEO, President at Damora Therapeutics, Inc. (DMRA); COO at Arcus Biosciences, Inc. (RCUS)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys+$11K
Total bought / sold$253K / $2.2M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 28SEC | DMRADamora Therapeutics, Inc. | Buy | 12,500512,500 held (+2%) | $20.23 | $253K | +4.2% |
| Dec 18SEC | RCUSArcus Biosciences, Inc. | Sell Plan | 11,225203,007 held (−5%) | $21.88 | $246K | +11.6% |
| Dec 18SEC | RCUSArcus Biosciences, Inc. | Sell Plan | 9,983193,024 held (−5%) | $22.16 | $221K | +10.2% |
| Nov 12SEC | RCUSArcus Biosciences, Inc. | Sell Plan | 50,291214,232 held (−19%) | $18.97 | $954K | +28.7% |
| Oct 8SEC | RCUSArcus Biosciences, Inc. | Sell Plan | 12,500214,232 held (−6%) | $14.54 | $182K | +67.9% |
| Oct 8SEC | RCUSArcus Biosciences, Inc. | Sell Plan | 37,792214,232 held (−15%) | $15.05 | $569K | +62.2% |
- Buy
CEO, President Jennifer Jarrett bought $253K of DMRA at $20.23 — first open-market purchase in our records.
- Sell
COO Jennifer Jarrett sold $246K of RCUS at $21.88 — pre-scheduled 10b5-1 plan sale.
- Sell
COO Jennifer Jarrett sold $221K of RCUS at $22.16 — pre-scheduled 10b5-1 plan sale.
- Sell
COO Jennifer Jarrett sold $954K of RCUS at $18.97 — pre-scheduled 10b5-1 plan sale.
- Sell
COO Jennifer Jarrett sold $182K of RCUS at $14.54 — pre-scheduled 10b5-1 plan sale.
- Sell
COO Jennifer Jarrett sold $569K of RCUS at $15.05 — pre-scheduled 10b5-1 plan sale.